Search for Stocks /

Colgate-Palmolive:105% ROCE. 81% ROE.Why This Stock Costs ₹2,205 and You’re Not Mad About It

Spotted a factual error — a wrong number, date, or fact? Tell us and we will check the source.
Colgate-Palmolive Q3 FY26 | EduInvesting
Q3 FY26 Results · Quarterly Reporting (Jan–Dec)

Colgate-Palmolive:
105% ROCE. 81% ROE.
Why This Stock Costs ₹2,205 and You’re Not Mad About It

Slow growth, high profitability, absolute dominance in India’s oral care. The company returned ₹1,671 crore to shareholders in FY25 — more than its entire PAT. Markets rewarded this genius with a 10% annual loss. Let’s unpack the contradiction.

Market Cap₹59,962 Cr
CMP₹2,205
P/E Ratio45.0x
Div Yield2.31%
ROCE105%

The Toothpaste Monopoly That Somehow Stays Boring

  • 52-Week High / Low₹2,747 / ₹2,029
  • FY25 Revenue (Full Year)₹6,040 Cr
  • FY25 PAT (Full Year)₹1,437 Cr
  • Full-Year EPS (FY25)₹52.83
  • TTM EPS₹48.79
  • Book Value₹58.2
  • Price to Book37.9x
  • Dividend Yield2.31%
  • Debt / Equity0.04x
  • Return (1 Year)-10.9%
Auditor’s Opening Note: Colgate-Palmolive closed FY25 with ₹6,040 crore revenue (−3% YoY on TTM basis), ₹1,437 crore PAT, and paid out ₹1,671 crore in dividends (151% payout ratio). The stock delivered −10.9% returns over 12 months. Meanwhile, ROCE sits at an absurd 105%, ROE at 81.2%, and P/E trades at 45x. This is what happens when you build a monopoly so good it becomes invisible. Everyone brushes with Colgate. Nobody thinks about Colgate as a portfolio. Until they check the returns, then they regret everything.

Meet the Company That’s Been Dentist-Recommended Since Your Grandparents Were in Braces

Colgate-Palmolive India: the toothpaste, tooth powder, toothbrush, and mouthwash company. No software, no blockchain, no “Web3 ready.” Just stuff you put in your mouth, spit out, and don’t think about again. Genius business model.

The numbers are ridiculous. ₹51% market share in toothpaste. ₹48% in tooth powder. The company hasn’t lost a quarter in living memory. Operating margins are locked at 30–33% year after year. The cash conversion cycle is negative (they collect from distributors before paying suppliers). They spend 13% of revenues on advertising and still dominate. This is competitive moat incarnate.

But here’s where the story gets interesting: growth has stalled. Full-year revenue in FY25 hit ₹6,040 crore — that’s −3% year-on-year on a TTM basis. Profit is flat. The stock has delivered −10.9% returns over 12 months. Yet the company keeps returning cash to shareholders at ratios that make even tech startups look miserly. They’re using equity capital like it costs nothing. And the market is somehow fine with it, even if the price action says otherwise.

So what’s happening at Colgate? Growth crisis? Pricing power maxed out? Or just a mature business extracting every possible rupee from a saturated market? Let’s find out — with data, spreadsheets, and the kind of honest-to-god analysis that a dentist would appreciate more than your twice-yearly checkup.

Recent News (Feb 2026): Colgate launched “Visible White Purple” campaign with Kriti Sanon. Rahul Dravid appointed as Colgate Total brand ambassador. The company is not giving up on growth — it’s just… hunting for it in very specific niches.

How They Became the Dental Monopoly That Escaped Antitrust

Read Full 16 Point breakdown. Continue reading →
EduInvesting runs entirely on reader support — ₹360 a year keeps the lights on.
Become a member
Already a member? Log in
Read Full 16 Point breakdown. Continue reading →